Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs SOTAC PHARMACEUTICALS LTD. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA SOTAC PHARMACEUTICALS LTD. BLISS GVS PHARMA/
SOTAC PHARMACEUTICALS LTD.
 
P/E (TTM) x 19.6 - - View Chart
P/BV x 1.5 2.9 51.2% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   SOTAC PHARMACEUTICALS LTD.
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-24
SOTAC PHARMACEUTICALS LTD.
Mar-24
BLISS GVS PHARMA/
SOTAC PHARMACEUTICALS LTD.
5-Yr Chart
Click to enlarge
High Rs149155 96.1%   
Low Rs7197 73.2%   
Sales per share (Unadj.) Rs73.694.0 78.3%  
Earnings per share (Unadj.) Rs7.83.2 240.6%  
Cash flow per share (Unadj.) Rs10.36.0 170.6%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs91.641.0 223.8%  
Shares outstanding (eoy) m104.6911.05 947.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.51.3 111.5%   
Avg P/E ratio x14.138.9 36.3%  
P/CF ratio (eoy) x10.720.8 51.2%  
Price / Book Value ratio x1.23.1 39.0%  
Dividend payout %6.40-   
Avg Mkt Cap Rs m11,5131,392 826.9%   
No. of employees `000NANA-   
Total wages/salary Rs m95620 4,671.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,7021,038 741.8%  
Other income Rs m3045 6,252.7%   
Total revenues Rs m8,0061,043 767.5%   
Gross profit Rs m1,19883 1,440.3%  
Depreciation Rs m26431 850.7%   
Interest Rs m6917 397.7%   
Profit before tax Rs m1,16940 2,948.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3534 9,167.3%   
Profit after tax Rs m81636 2,279.4%  
Gross profit margin %15.68.0 194.2%  
Effective tax rate %30.29.7 311.3%   
Net profit margin %10.63.4 307.2%  
BALANCE SHEET DATA
Current assets Rs m8,116606 1,338.3%   
Current liabilities Rs m1,598437 365.5%   
Net working cap to sales %84.616.3 519.4%  
Current ratio x5.11.4 366.2%  
Inventory Days Days129 128.2%  
Debtors Days Days1,916924 207.3%  
Net fixed assets Rs m4,022433 929.9%   
Share capital Rs m105111 94.7%   
"Free" reserves Rs m9,490342 2,774.1%   
Net worth Rs m9,595453 2,119.9%   
Long term debt Rs m356121 293.4%   
Total assets Rs m12,1391,039 1,168.3%  
Interest coverage x17.93.3 545.9%   
Debt to equity ratio x00.3 13.8%  
Sales to assets ratio x0.61.0 63.5%   
Return on assets %7.35.1 142.4%  
Return on equity %8.57.9 107.5%  
Return on capital %12.49.9 125.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6070-   
Fx outflow Rs m8960-   
Net fx Rs m4,7110-   
CASH FLOW
From Operations Rs m1,524-161 -945.6%  
From Investments Rs m-1,328-197 674.9%  
From Financial Activity Rs m-209295 -70.7%  
Net Cashflow Rs m-14-63 22.6%  

Share Holding

Indian Promoters % 34.8 72.9 47.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.7 8.9 210.6%  
FIIs % 12.1 8.9 136.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 65.2 27.2 240.1%  
Shareholders   52,937 251 21,090.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on BLISS GVS PHARMA vs SOTAC PHARMACEUTICALS LTD.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs SOTAC PHARMACEUTICALS LTD. Share Price Performance

Period BLISS GVS PHARMA SOTAC PHARMACEUTICALS LTD. S&P BSE HEALTHCARE
1-Day 1.67% 0.00% 0.89%
1-Month 23.06% -1.18% 1.21%
1-Year -7.52% -10.15% 46.19%
3-Year CAGR 10.33% -1.29% 19.62%
5-Year CAGR -0.92% -0.77% 26.11%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the SOTAC PHARMACEUTICALS LTD. share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 34.8% stake in the company. In case of SOTAC PHARMACEUTICALS LTD. the stake stands at 72.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of SOTAC PHARMACEUTICALS LTD..

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.4%.

SOTAC PHARMACEUTICALS LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of SOTAC PHARMACEUTICALS LTD..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.